Cytokinetics (CYTK) Q2 2021 Earnings

6MayConfirmed
Q3 2020
Q4 2020
Q1 2021
Q2 2021
-0.68
-0.47
-0.26
-0.05

Details

Expected EPS
-0.6
Actual EPS
-0.66
Surprise EPS
-0.06
Surprise Percent
+10%

Description

Cytokinetics (CYTK) has reported earnings of -0.66 per share for Q2 2021.

0 Comments

Share your thoughts